Comparative Effectiveness of Alternative Intervals between First and Second Doses of the mRNA COVID-19 Vaccines: a Trial Emulation Approach
View ORCID ProfileKayoko Shioda, Alexander Breskin, Pravara Harati, Allison Chamberlain, Benjamin A Lopman, Elizabeth T. Rogawski McQuade
doi: https://doi.org/10.1101/2023.03.06.23286848
Kayoko Shioda
1Gangarosa Department of Environmental Health and Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA
PhD, DVM, MPHAlexander Breskin
2Regeneron Pharmaceuticals, Tarrytown, NY, USA; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
PhD, MPHPravara Harati
3Georgia Department of Public Health, Atlanta, GA, USA
Allison Chamberlain
4Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA
PhD, MSBenjamin A Lopman
4Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA
PhDElizabeth T. Rogawski McQuade
4Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA
PhD, MSPHData Availability
Individual-level data on COVID-19 test results from the Georgia State Electronic Notifiable Disease Surveillance System (SendSS) and COVID-19 vaccination from the Georgia Department of Public Health (GDPH) are also not publicly available, but aggregated data are available on the GDPH COVID-19 website.
Posted March 08, 2023.
Comparative Effectiveness of Alternative Intervals between First and Second Doses of the mRNA COVID-19 Vaccines: a Trial Emulation Approach
Kayoko Shioda, Alexander Breskin, Pravara Harati, Allison Chamberlain, Benjamin A Lopman, Elizabeth T. Rogawski McQuade
medRxiv 2023.03.06.23286848; doi: https://doi.org/10.1101/2023.03.06.23286848
Comparative Effectiveness of Alternative Intervals between First and Second Doses of the mRNA COVID-19 Vaccines: a Trial Emulation Approach
Kayoko Shioda, Alexander Breskin, Pravara Harati, Allison Chamberlain, Benjamin A Lopman, Elizabeth T. Rogawski McQuade
medRxiv 2023.03.06.23286848; doi: https://doi.org/10.1101/2023.03.06.23286848
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2885)
- Dermatology (247)
- Emergency Medicine (433)
- Epidemiology (12626)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4487)
- Geriatric Medicine (410)
- Health Economics (717)
- Health Informatics (2870)
- Health Policy (1059)
- Hematology (379)
- HIV/AIDS (912)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4254)
- Nursing (228)
- Nutrition (622)
- Oncology (2229)
- Ophthalmology (635)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6834)
- Radiology and Imaging (1504)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (376)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)